Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of General Anesthesia on Pharmacokinetics and Pharmacogenomics of Liquid Oxycodone in Pediatric Surgical Patients
NCT03054831Phase 4Active, not recruiting
- Sponsor
- Boston Children's Hospital
- Start
- Jul 2019
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxycodone in pain (4 arms), sponsored by Boston Children's Hospital. Primary endpoint: Plasma oxycodone level at 24 weeks. Started Jul 2019; status: active, not recruiting.
02
Drugs
oxycodone
03
Conditions
pain
Beyond the preview
Go deeper on NCT03054831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03054831.